BGM Associates
  • What we do
    • Our services
    • Our Focus
  • Who we are
    • People
    • Advisory Board
  • Our Thinking
  • News
  • Careers
  • Contact us
  • What we do
    • Our services
    • Our Focus
  • Who we are
    • People
    • Advisory Board
  • Our Thinking
  • News
  • Careers
  • Contact us

NEWS

News about our organization and our activities​​

ImaginAb and DuChemBio Co. Ltd., signed a Manufacturing and Distribution partnership for South Korea and North-Asia

20/6/2022

 
Picture
ImaginAb, Inc., a market leading global biotechnology company, and DuChemBio Co., Ltd., a South Korea’s leading radiopharmaceutical company advised by BGM Associates, have recently announced the signing of a Manufacturing and Distribution Partnership to manufacture and supply ImaginAb’s proprietary investigational CD8 ImmunoPET agent Zirconium 89Zr-crefmirlimab berdoxam to pharmaceutical sponsored clinical trials, as well as investigator initiated trials in South Korea.
​The Agreement allows DuChemBio, who operates the largest radiopharmaceutical  network in South Korea, to manufacture and distribute the radiotracer for clinical investigations, and to commercialize the product post regulatory approval in South Korea. In addition, the agreement also opens a  distribution opportunity for DuChemBio to supply ImaginAb’s CD8-targeting tracers to other Asian countries. 
Full Press Release

Comments are closed.

    BGM News Blog

    We regularly publish news from within our firm and our focus industries

    News categories

    All
    Events
    Management & Personnel
    Projects
    Publications & Presentations

    View my profile on LinkedIn

CONNECT WITH US

info@bgmassociates.com
+49  30  8148  7127

VISIT OUR OFFICE

Winkler Straße 11
14193 Berlin – Germany

 

© COPYRIGHT 2012-2019. ALL RIGHTS RESERVED | ​TERMS OF USE | LEGAL NOTICE | PRIVACY POLICY